BET inhibitor

This page covers all BET inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting BET proteins.

Targets

BET proteins

Phase 2 pipeline (1)

• BET Inhibitor · Bristol-Myers Squibb · Oncology
  BET inhibitor targets bromodomain and extra-terminal domain (BET) proteins

Patent intelligence

• bet inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates